Laxative

FDA Drug Profile — CEO-TWO, Laxative

Laxative is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including CEO-TWO, Laxative. Available dosage forms: suppository, tablet, sugar coated.

Drug details

Generic Name
Laxative
Brand Names
CEO-TWO, Laxative
Application Number
M007
Sponsor
Beutlich Pharmaceuticals, LLC
NDC Codes
2
Dosage Forms
SUPPOSITORY, TABLET, SUGAR COATED
Routes
RECTAL, ORAL
Active Ingredients
POTASSIUM BITARTRATE, SODIUM BICARBONATE, DEACETYLBISACODYL

Indications and Usage

Use(s) for temporary relief of occasional constipation and irregularity this product generally produces bowel movement in 6 to 12 hours

Warnings

Warnings Do not use if you cannot swallow without chewing Ask a doctor before use if you stomach pain, nausea or vomiting a sudden change in bowel habits that lasts more than 2 weeks Ask a doctor or pharmacist before use if When using this product do not chew or crush tablet(s) do not use within 1 hour after taking an antacid or milk you may have stomach discomfort, faintness and cramps Stop use and ask a doctor before use if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. you need to use a laxative for more than 1 week If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.